Stockreport

TALVEY®? (talquetamab) demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF BEERSE, BELGIUM , June 14, 2024 (GLOBE NEWSWIRE) -- Janssen-Cilag International NV, a Johnson & Johnson company announced today that long-term data from the Phase 1/2 M [Read more]